[
  {
    "ts": "2026-02-03T00:00:00+00:00",
    "headline": "AMD earnings, Netflix-Warner Bros. hearing: What to Watch",
    "summary": "Market Domination Overtime Host Josh Lipton previews several of the biggest stories to come tomorrow, Tuesday, February 3, including earnings results from companies like Advanced Micro Devices (AMD), Chipotle Mexican Grill (CMG), Pfizer (PFE), and Merck (MRK), and the Senate hearing on Netflix's (NFLX) proposed bid to acquire Warner Bros. Discovery (WBD). To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Domination Overtime.",
    "url": "https://finance.yahoo.com/video/amd-earnings-netflix-warner-bros-000000934.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "944ac714-6d5e-3cf9-ac3d-5262ebfd6519",
      "content": {
        "id": "944ac714-6d5e-3cf9-ac3d-5262ebfd6519",
        "contentType": "VIDEO",
        "title": "AMD earnings, Netflix-Warner Bros. hearing: What to Watch",
        "description": "<p>Market Domination Overtime Host <a data-i13n=\"cpos:1;pos:1\" href=\"https://www.yahoo.com/author/josh-lipton/\">Josh Lipton</a> previews several of the biggest stories to come tomorrow, Tuesday, February 3, including earnings results from companies like Advanced Micro Devices (<a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/quote/AMD\">AMD</a>), Chipotle Mexican Grill (<a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/CMG\">CMG</a>), Pfizer (<a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/PFE\">PFE</a>), and Merck (<a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/quote/MRK\">MRK</a>), and the Senate hearing on Netflix's (<a data-i13n=\"cpos:6;pos:1\" href=\"https://finance.yahoo.com/quote/NFLX\">NFLX</a>) proposed bid to acquire Warner Bros. Discovery (<a data-i13n=\"cpos:7;pos:1\" href=\"https://finance.yahoo.com/quote/WBD\">WBD</a>).</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:8;pos:1\" href=\"https://finance.yahoo.com/videos/series/market-domination-overtime/\">Market Domination Overtime</a>.</p>",
        "summary": "Market Domination Overtime Host Josh Lipton previews several of the biggest stories to come tomorrow, Tuesday, February 3, including earnings results from companies like Advanced Micro Devices (AMD), Chipotle Mexican Grill (CMG), Pfizer (PFE), and Merck (MRK), and the Senate hearing on Netflix's (NFLX) proposed bid to acquire Warner Bros. Discovery (WBD). To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Domination Overtime.",
        "pubDate": "2026-02-03T00:00:00Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2026-02/67792e30-0073-11f1-bfff-3c4891fc6d0b",
          "originalWidth": 1920,
          "originalHeight": 1080,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UzqQCDUXj0MPW_tlpZ7E0A--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2026-02/67792e30-0073-11f1-bfff-3c4891fc6d0b.cf.webp",
              "width": 1920,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/n0CeAGm.cJ44Rdq8zCs3Mw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2026-02/67792e30-0073-11f1-bfff-3c4891fc6d0b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/amd-earnings-netflix-warner-bros-000000934.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/amd-earnings-netflix-warner-bros-000000934.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NFLX"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "PYPL"
            },
            {
              "symbol": "CMG"
            },
            {
              "symbol": "WBD"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T03:14:36+00:00",
    "headline": "Assessing Amgen (AMGN) Valuation After Ending Kyowa Kirin Rocatinlimab Collaboration",
    "summary": "Amgen (AMGN) has just walked away from its licensing and collaboration agreement with Kyowa Kirin on rocatinlimab for atopic dermatitis, a portfolio reshuffle that shifts responsibility back to Kyowa Kirin and repositions Amgen’s near term pipeline focus. See our latest analysis for Amgen. Those portfolio moves sit alongside a share price that has climbed to US$344.68, with a 30 day share price return of 5.2% and a 1 year total shareholder return of 23.14%, which suggests that momentum has...",
    "url": "https://finance.yahoo.com/news/assessing-amgen-amgn-valuation-ending-031436152.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "366cb14c-8d29-3a75-b321-72cb70abcf98",
      "content": {
        "id": "366cb14c-8d29-3a75-b321-72cb70abcf98",
        "contentType": "STORY",
        "title": "Assessing Amgen (AMGN) Valuation After Ending Kyowa Kirin Rocatinlimab Collaboration",
        "description": "",
        "summary": "Amgen (AMGN) has just walked away from its licensing and collaboration agreement with Kyowa Kirin on rocatinlimab for atopic dermatitis, a portfolio reshuffle that shifts responsibility back to Kyowa Kirin and repositions Amgen’s near term pipeline focus. See our latest analysis for Amgen. Those portfolio moves sit alongside a share price that has climbed to US$344.68, with a 30 day share price return of 5.2% and a 1 year total shareholder return of 23.14%, which suggests that momentum has...",
        "pubDate": "2026-02-03T03:14:36Z",
        "displayTime": "2026-02-03T03:14:36Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ACuIXYrNeojUXbAJFhnPIg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/B7CQJIEa.2c0sQ0XIU66pg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/assessing-amgen-amgn-valuation-ending-031436152.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/assessing-amgen-amgn-valuation-ending-031436152.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "KYKOF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T12:24:06+00:00",
    "headline": "Jim Cramer on Amgen: “The Biotech Really Impressed Me With a Very Strong Pipeline”",
    "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the stocks on Jim Cramer’s recent game plan. Cramer said that he heard good things about the company during the JPMorgan Healthcare Conference, as he commented: With Amgen, I don’t know if you remember, at the JPMorgan Healthcare Conference, I heard a lot of good things. The biotech really […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-amgen-biotech-really-122406856.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "9e113368-7116-3838-a81d-867e64833c7c",
      "content": {
        "id": "9e113368-7116-3838-a81d-867e64833c7c",
        "contentType": "STORY",
        "title": "Jim Cramer on Amgen: “The Biotech Really Impressed Me With a Very Strong Pipeline”",
        "description": "",
        "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the stocks on Jim Cramer’s recent game plan. Cramer said that he heard good things about the company during the JPMorgan Healthcare Conference, as he commented: With Amgen, I don’t know if you remember, at the JPMorgan Healthcare Conference, I heard a lot of good things. The biotech really […]",
        "pubDate": "2026-02-03T12:24:06Z",
        "displayTime": "2026-02-03T12:24:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/753cb9cb32336de8f86289f7a7c7b36e",
          "originalWidth": 6144,
          "originalHeight": 3456,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yUwpYgqiuVEAjPqpC4y7Ww--~B/aD0zNDU2O3c9NjE0NDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/753cb9cb32336de8f86289f7a7c7b36e.cf.webp",
              "width": 6144,
              "height": 3456,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Q.HNxvelm8rTEuW9n.Ys6Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/753cb9cb32336de8f86289f7a7c7b36e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-amgen-biotech-really-122406856.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-amgen-biotech-really-122406856.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T12:16:17+00:00",
    "headline": "Stocks Mostly Rise Pre-Bell as Investors Await Latest Round of Corporate Earnings",
    "summary": "US equity futures were mostly pointing higher on Tuesday as traders await a fresh batch of corporate",
    "url": "https://finance.yahoo.com/news/stocks-mostly-rise-pre-bell-121617545.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "36c8c3ff-12fb-31be-8c10-4a8d88132e3c",
      "content": {
        "id": "36c8c3ff-12fb-31be-8c10-4a8d88132e3c",
        "contentType": "STORY",
        "title": "Stocks Mostly Rise Pre-Bell as Investors Await Latest Round of Corporate Earnings",
        "description": "",
        "summary": "US equity futures were mostly pointing higher on Tuesday as traders await a fresh batch of corporate",
        "pubDate": "2026-02-03T12:16:17Z",
        "displayTime": "2026-02-03T12:16:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/8685121785649cec3dbcdbbd25333a86",
          "originalWidth": 1024,
          "originalHeight": 683,
          "caption": "wall street stock market flag new york trading equity - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QVMgErJdOR7IkzCjRHm3pQ--~B/aD02ODM7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/8685121785649cec3dbcdbbd25333a86.cf.webp",
              "width": 1024,
              "height": 683,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dimQxOClk1isv1IKNf9JtA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/8685121785649cec3dbcdbbd25333a86.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/stocks-mostly-rise-pre-bell-121617545.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stocks-mostly-rise-pre-bell-121617545.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TER"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "NXPI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "ITW"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "MDLZ"
            },
            {
              "symbol": "CMG"
            },
            {
              "symbol": "EA"
            },
            {
              "symbol": "TDG"
            },
            {
              "symbol": "PYPL"
            },
            {
              "symbol": "ADM"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "EMR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T11:26:22+00:00",
    "headline": "Nasdaq Futures Climb on Blowout Palantir Results",
    "summary": "March Nasdaq 100 E-Mini futures (NQH26) are trending up +0.41% this morning as forecast-beating quarterly results and guidance from Palantir Technologies boosted sentiment.",
    "url": "https://www.barchart.com/story/news/37377340/nasdaq-futures-climb-on-blowout-palantir-results",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "a13bd3a0-c685-3674-9604-35354efa5f0b",
      "content": {
        "id": "a13bd3a0-c685-3674-9604-35354efa5f0b",
        "contentType": "STORY",
        "title": "Nasdaq Futures Climb on Blowout Palantir Results",
        "description": "",
        "summary": "March Nasdaq 100 E-Mini futures (NQH26) are trending up +0.41% this morning as forecast-beating quarterly results and guidance from Palantir Technologies boosted sentiment.",
        "pubDate": "2026-02-03T11:26:22Z",
        "displayTime": "2026-02-03T11:26:22Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/9a1ff5003151ccd77c6a21a4e3c76ded",
          "originalWidth": 1600,
          "originalHeight": 1068,
          "caption": "Nasdaq Times Square by Lucky Photographer via iStock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1TEunvsuvYg5NCUJL7Pj0g--~B/aD0xMDY4O3c9MTYwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/barchart_com_477/9a1ff5003151ccd77c6a21a4e3c76ded.cf.webp",
              "width": 1600,
              "height": 1068,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gAXtlTbrflDl0BGZshHWaQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/9a1ff5003151ccd77c6a21a4e3c76ded.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/37377340/nasdaq-futures-climb-on-blowout-palantir-results",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nasdaq-futures-climb-blowout-palantir-112622644.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NQH26"
            },
            {
              "symbol": "TER"
            },
            {
              "symbol": "DIS"
            },
            {
              "symbol": "INTC"
            },
            {
              "symbol": "PEP"
            },
            {
              "symbol": "MU"
            },
            {
              "symbol": "RMBS"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "AMUN.P.DX"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "GC=F"
            },
            {
              "symbol": "SNDK"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T18:27:28+00:00",
    "headline": "Obesity stocks slump on Novo's underwhelming 2026 sales forecast",
    "summary": "Feb 3 (Reuters) - Shares of obesity drugmakers and developers slid on Tuesday after Novo Nordisk forecast a sharper-than-expected sales decline for 2026, underscoring intensifying competition in the",
    "url": "https://ca.finance.yahoo.com/news/obesity-stocks-slump-novos-underwhelming-182728439.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "3b7b0f91-d0a3-3f96-8fa5-abf29677ceaa",
      "content": {
        "id": "3b7b0f91-d0a3-3f96-8fa5-abf29677ceaa",
        "contentType": "STORY",
        "title": "Obesity stocks slump on Novo's underwhelming 2026 sales forecast",
        "description": "",
        "summary": "Feb 3 (Reuters) - Shares of obesity drugmakers and developers slid on Tuesday after Novo Nordisk forecast a sharper-than-expected sales decline for 2026, underscoring intensifying competition in the",
        "pubDate": "2026-02-03T18:27:28Z",
        "displayTime": "2026-02-03T18:27:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/ed0f16ee519c89d890321f14cbb468f8",
          "originalWidth": 800,
          "originalHeight": 533,
          "caption": "FILE PHOTO: A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, and boxes of Wegovy, made by Novo Nordisk. REUTERS/Hollie Adams/Brendan McDermid/Combination/File Photo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dNztZcR2q0tet4W_8rBY4A--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/ed0f16ee519c89d890321f14cbb468f8.cf.webp",
              "width": 800,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Sz3cScsHUSaL4rHQnnECuw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/ed0f16ee519c89d890321f14cbb468f8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://ca.finance.yahoo.com/news/obesity-stocks-slump-novos-underwhelming-182728439.html",
          "site": "finance",
          "region": "CA",
          "lang": "en-CA"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/obesity-stocks-slump-novos-underwhelming-182728439.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "VKTX"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "GPCR"
            },
            {
              "symbol": "ALT"
            }
          ],
          "premiumFinance": null
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T19:00:48+00:00",
    "headline": "Equities Fall Intraday as Tech Sector Slumps; Precious Metals Jump",
    "summary": "US benchmark equity indexes were lower intraday amid a plunge in the technology sector, while gold a",
    "url": "https://finance.yahoo.com/news/equities-fall-intraday-tech-sector-190048469.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "0e50bfa2-3c6b-3996-9c5e-5468df41497a",
      "content": {
        "id": "0e50bfa2-3c6b-3996-9c5e-5468df41497a",
        "contentType": "STORY",
        "title": "Equities Fall Intraday as Tech Sector Slumps; Precious Metals Jump",
        "description": "",
        "summary": "US benchmark equity indexes were lower intraday amid a plunge in the technology sector, while gold a",
        "pubDate": "2026-02-03T19:00:48Z",
        "displayTime": "2026-02-03T19:00:48Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/0c887a492733aab96ac405a5871f559a",
          "originalWidth": 1024,
          "originalHeight": 768,
          "caption": "Stocks_Chart market equity trading wall street - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0eWqzzTTIs4ZCQG0VOzLjA--~B/aD03Njg7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/0c887a492733aab96ac405a5871f559a.cf.webp",
              "width": 1024,
              "height": 768,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/woUn3cfJYPXMhxA4_4CCeg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/0c887a492733aab96ac405a5871f559a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/equities-fall-intraday-tech-sector-190048469.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/equities-fall-intraday-tech-sector-190048469.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GC=F"
            },
            {
              "symbol": "SI=F"
            },
            {
              "symbol": "IBM"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "CRM"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "MSFT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T20:07:11+00:00",
    "headline": "Amgen Lawsuit Over 340B Discounts As Stock Trades Near Valuation Targets",
    "summary": "Amgen is being sued over an alleged unlawful decision to end discounted drug sales to Sagebrush Health Services under the federal 340B Drug Pricing Program. The lawsuit claims the move restricts access to lower cost medications for patients served by Sagebrush, which focuses on underserved communities. The case centers on Amgen's compliance with 340B rules that aim to reduce drug costs for vulnerable patient groups. For investors watching NasdaqGS:AMGN, this legal dispute arrives with the...",
    "url": "https://finance.yahoo.com/news/amgen-lawsuit-over-340b-discounts-200711867.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "359257c3-4d16-356c-a6a9-2d716c75a89f",
      "content": {
        "id": "359257c3-4d16-356c-a6a9-2d716c75a89f",
        "contentType": "STORY",
        "title": "Amgen Lawsuit Over 340B Discounts As Stock Trades Near Valuation Targets",
        "description": "",
        "summary": "Amgen is being sued over an alleged unlawful decision to end discounted drug sales to Sagebrush Health Services under the federal 340B Drug Pricing Program. The lawsuit claims the move restricts access to lower cost medications for patients served by Sagebrush, which focuses on underserved communities. The case centers on Amgen's compliance with 340B rules that aim to reduce drug costs for vulnerable patient groups. For investors watching NasdaqGS:AMGN, this legal dispute arrives with the...",
        "pubDate": "2026-02-03T20:07:11Z",
        "displayTime": "2026-02-03T20:07:11Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ACuIXYrNeojUXbAJFhnPIg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/B7CQJIEa.2c0sQ0XIU66pg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-lawsuit-over-340b-discounts-200711867.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-lawsuit-over-340b-discounts-200711867.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]